FDA Drug Recalls

Recalls / Class III

Class IIID-0813-2021

Product

Sirolimus Tablets 1 mg, 30 Tablets (5 blister cards x 6 unit doses), Rx only, Packaged and Distributed by: American Health Packaging Columbus, OH 43217, NDC 68084-915-25

Brand name
Sirolimus
Generic name
Sirolimus
Active ingredient
Sirolimus
Route
Oral
NDC
68084-915
FDA application
ANDA201578
Affected lot / code info
Lot #: 1000789, Exp. Date 10/31/2022

Why it was recalled

Failed Impurities/Degradation Specifications

Recalling firm

Firm
American Health Packaging
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2550 John Glenn Ave Ste A, Columbus, Ohio 43217-1188

Distribution

Quantity
290 cartons
Distribution pattern
Nationwide within the USA

Timeline

Recall initiated
2021-05-12
FDA classified
2021-09-20
Posted by FDA
2021-09-29
Terminated
2022-08-25
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0813-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Sirolimus · FDA Drug Recalls